Grifols to Testify in Canadian Parliamentary Hearing After Plasma Donation Deaths

Spanish pharmaceutical company Grifols is set to appear before a parliamentary hearing in Canada. Bloomberg posted on X that this follows the recent deaths of two individuals who had donated blood plasma. The hearing aims to investigate the circumstances surrounding these incidents and assess the safety protocols in place for plasma donations. Grifols, a major player in the global blood plasma market, will provide insights into its operations and safety measures. The company has expressed its commitment to cooperating fully with Canadian authorities to ensure transparency and address any concerns related to the plasma donation process.